Trump signs order directing CDC to align with assessment calling for fewer childhood vaccines President Trump signed an executive order on Friday directing the U.S. Centers for Disease Control and Prevention (CDC) to align with a scientific assessment released earlier in the year by the Department of Health and Human Services (HHS) that advocates for reducing the number of childhood vaccines recommended. The order mandates the CDC and its Advisory Committee on Immunization Practices (ACIP) to review the HHS assessment and the latest clinical data, then take any necessary steps to update the U.S. childhood and adolescent vaccine schedule. The move follows a December memo issued by Trump instructing HHS to align U.S. childhood vaccine recommendations with "best practices from peer, developed countries." In early January, HHS released an assessment concluding that the U.S. recommends more childhood vaccines than any other peer nation and more than twice as many doses as some European countries. The report highlighted that the U.S. schedule includes vaccines for diseases such as respiratory syncytial virus (RSV), hepatitis A, hepatitis B, dengue, meningococcal ACWY, and meningococcal B, which are recommended only for high-risk children. However, the CDC retained recommendations for 11 diseases, including measles, mumps, rubella, pertussis, tetanus, diphtheria, Hib, pneumonia, polio, HPV, and varicella. The executive order was met with significant backlash from medical experts and health organizations, including the American Academy of Pediatrics (AAP). The AAP, which criticized the HHS assessment, released its own childhood vaccine recommendations, diverging from CDC guidance. The White House defended the order, stating it reaffirms Trump’s commitment to "gold-standard science" and empowers patients and doctors with "maximum flexibility.#trump #cdc #robert_f_kennedy_jr #hhs #acip
HHS Launches Plan to Address Overprescribing of Psychiatric Medications U.S. Health and Human Services Secretary Robert F. Kennedy Jr. unveiled a federal initiative Monday aimed at curbing the overprescription of psychiatric medications and promoting alternative treatments. The plan, announced at the MAHA Institute summit on mental health and overmedicalization, emphasizes patient autonomy, informed consent, and a shift toward holistic care. Kennedy framed the effort as a critical step in addressing the nation’s mental health crisis, particularly among children, by reducing reliance on psychiatric drugs and prioritizing prevention and transparency. The initiative follows recent advocacy by mental health professionals, including guidelines from the American Society of Clinical Psychopharmacology published in February, which outline criteria for evaluating when discontinuation of medications is appropriate. While some experts welcomed the federal push for improved psychiatric care, they also raised concerns about potential overemphasis on overprescribing amid existing gaps in mental health access. Kennedy’s efforts are part of his broader “Make America Healthy Again” movement, which has targeted psychiatric medications since his appointment last year. He has claimed these drugs are overused and linked to risks such as violence, mass shootings, fetal harm during pregnancy, severe withdrawal symptoms, and adverse effects on children. However, the U.S. Food and Drug Administration has consistently deemed antidepressants and other psychiatric medications safe and effective for conditions like depression, anxiety, eating disorders, and obsessive-compulsive disorder.#robert_f_kennedy_jr #hhs #maha_institute_summit #american_society_of_clinical_psychopharmacology #american_psychiatric_association
